From October 1, 2023 to December 31, 2023, the company has repurchased 11,511,800 shares, representing 0.6% for CNY 53.54 million. With this, the company has completed the repurchase of 27,531,540 shares, representing 1.42% for CNY 127.48 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.31 CNY | -0.30% |
|
-1.49% | -25.45% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.45% | 871M | |
+26.93% | 5.6B | |
-33.55% | 3.53B | |
-3.74% | 3.03B | |
-26.09% | 2.58B | |
-10.93% | 2.31B | |
+41.50% | 1.86B | |
+41.84% | 1.45B | |
+47.62% | 1.41B | |
-28.07% | 1.27B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.